Skip to search formSkip to main contentSkip to account menu

ebrotidine

Known as: 4-bromo-N-(((2-(((-((diaminomethylene)amino)-4-thiazolyl)methyl)thio)ethyl)amino)methylene)benzenesulfonamide 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
This paper illustrates the possibilities of chemometric methods in the resolution and quantification of various compounds in… 
2000
2000
Ebrotidine is an antagonist of the histamine H2 receptors, with antisecretory and cytoprotective properties demonstrated in… 
1999
1999
UNLABELLED Helicobacter pylori lipopolysaccharide is a primary virulence factor responsible for eliciting acute mucosal… 
1997
1997
Ebrotidine (N-[(E)-[[2-[[[2-[(diaminomethylene)-4-thiazolyl]methyl]thio] ethyl]amino]methylene]-4-bromo-benzenesulfonamide, CAS… 
1997
1997
The in vitro anti-Helicobacter pylori (H. pylori) activity of ebrotidine (N-[(E)-[[2-[[[2-[(diaminomethylene) amino]-4-thiazolyl… 
Review
1996
Review
1996
Ebrotidine is the first of a new generation of H2 receptor antagonists with gastroprotective activity It stimulates epithelial… 
1995
1995
Electrospray ionization was used for the analysis of ebrotidine and its potential metabolites. Since standard electrospray gave… 
1992
1992
This study was designed to assess the gastroprotective and secretory effects of ebrotidine, a novel H2-receptor antagonist, in… 
1992
1992
Ebrotidine is a novel H2-receptor antagonist that exhibits both gastroprotective and ulcer-healing properties. Gastroprotection…